Chairman, Fortis C-Doc Centre of Excellence for Diabetes and Endocrinology, Chairman National Diabetes, Obesity and Cholesterol Foundation (N.DOC) President, Diabetes Foundation India (DF), New Delhi

This panel discussion brings together key perspectives on the interplay between heart, metabolic, and renal health, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations are reshaping outcomes in patients with diabetes and associated co-morbidities. The session focuses on real-world evidence, patient selection, cardio-renal protection, and practical treatment strategies to achieve comprehensive cardio-renal-metabolic benefits in routine clinical practice.

Dr. Prof Anoop Misra

-

-

-

-

Upcoming Sessions